1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2000 AVOCENT CORPORATION (Exact Name of Registrant as Specified in Charter) DELAWARE 000-30575 91-2032368 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 4991 CORPORATE DRIVE HUNTSVILLE, ALABAMA 35805 (Address of Principal Executive Offices/Zip Code) (205) 430-4000 (Registrant's telephone number, including area code) 2 Item 2. Acquisition or Disposition of Assets. As previously reported in the Registrant's Current Report on Form 8-K, dated November 18, 2000, the Registrant entered into a Plan and Agreement of Merger, dated as of November 3, 2000, with respect to a merger (the "Merger") by and among Blue Marlin Acquisition Corporation, a Florida corporation and wholly-owned subsidiary of the Registrant (the "Subsidiary"), Equinox Systems Inc., a Florida corporation ("Equinox") and the Registrant, with the Registrant continuing as the surviving corporation. The Merger was consummated on January 3, 2001, prior to which the shareholders of Equinox duly approved the Merger in accordance with the corporate laws of the State of Florida. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (a) Financial Statements of Business Acquired. It is impractical to provide financial statements related to the transactions described herein at this time. If required, such financial statements will be filed within sixty (60) days of the date of the filing of this Form 8-K Current Report. (b) Pro Forma Financial Information. If required, such pro forma financial statements will be filed within sixty (60) days of the date of the filing of this Form 8-K Current Report. (c) Exhibits. None. SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVOCENT CORPORATION Dated: January 18, 2001 By: /s/ Doyle C. Weeks ------------------------------------------ Doyle C. Weeks Executive Vice President